Artelo Biosciences Inc (ARTL)

Jul 22, 2025

Artelo Biosciences Inc. Stock Analysis and ForecastSkyrocketing returns - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

What analysts say about Artelo Biosciences Inc. stockConsistently superior profits - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

What drives Artelo Biosciences Inc. stock priceRobust investment performance - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

What makes Artelo Biosciences Inc. stock price move sharplyStable Stocks With High Yield - Newser

Jul 22, 2025

Jul 20, 2025

Artelo Biosciences Announces $6.5 Million At-The-Market Offering Agreement - AInvest

Jul 20, 2025

Jul 19, 2025

Is Artelo Biosciences Inc. a good long term investmentFree Stock Market Real-Time Monitoring - jammulinksnews.com

Jul 19, 2025

Jul 19, 2025

Artelo Biosciences' ATM Offering: A Delicate Balance Between Liquidity and Dilution - AInvest

Jul 19, 2025

Jul 18, 2025

Artelo Biosciences Announces At-The-Market Offering Agreement - TipRanks

Jul 18, 2025

Jul 18, 2025

What analysts say about Artelo Biosciences Inc. stock outlookMinimized Risk Maximum Return - Newser

Jul 18, 2025

Jul 15, 2025

Why Artelo Biosciences Inc. stock attracts strong analyst attentionFree Join Group - Newser

Jul 15, 2025

Jul 15, 2025

How Artelo Biosciences Inc. stock performs during market volatilityFree Smart Money Stock Analysis - Newser

Jul 15, 2025

Jul 14, 2025

Artelo Biosciences Plummets Over 22%—What's Driving the Freefall? - AInvest

Jul 14, 2025

Jul 13, 2025

Artelo Biosciences Stock Soars 114% After Promising Depression Treatment Data - MSN

Jul 13, 2025

Jul 12, 2025

Artelo Biosciences Shares Climb on Promising Preclinical Osteoarthritis Pain Data - MSN

Jul 12, 2025

Jul 11, 2025

Artelo Biosciences Plans to Offer 920K Shares of Common Stock - AInvest

Jul 11, 2025

Jul 11, 2025

Artelo Biosciences completes reverse stock split and reports preliminary Q2 financials - Investing.com Nigeria

Jul 11, 2025

Jul 10, 2025

D. Boral Capital Upgrades Artelo Biosciences (NASDAQ:ARTL) to Buy - Defense World

Jul 10, 2025

Jul 10, 2025

D Boral Capital Upgrades Artelo Biosciences (NASDAQ:ARTL) to Strong-Buy - Defense World

Jul 10, 2025

Jul 10, 2025

Artelo Biosciences presents positive data for arthritis pain drug By Investing.com - Investing.com South Africa

Jul 10, 2025

Jul 09, 2025

Artelo Biosciences stock soars after positive preclinical pain data By Investing.com - Investing.com Nigeria

Jul 09, 2025

Jul 09, 2025

Artelo Biosciences stock soars after positive preclinical pain data - Investing.com

Jul 09, 2025

Jul 09, 2025

Artelo Biosciences Announces Positive Preclinical Efficacy Data for Art26.12 in Osteoarthritis Pain At the 35Th Annual International Cannabinoid Research Society Symposium - MarketScreener

Jul 09, 2025

Jul 09, 2025

Artelo Biosciences announces preclinical efficacy results of ART26.12 - TipRanks

Jul 09, 2025

Jul 09, 2025

Artelo Biosciences Soars 30.5% on Promising Depression Drug Data - AInvest

Jul 09, 2025

Jul 09, 2025

Artelo Biosciences Announces Positive Preclinical Efficacy Data for ART26.12 in Osteoarthritis Pain at the 35th Annual International Cannabinoid Research Society Symposium - The Manila Times

Jul 09, 2025

Jul 09, 2025

Artelo Biosciences presents positive data for arthritis pain drug - Investing.com

Jul 09, 2025

Jul 09, 2025

Artelo Biosciences Presents Preclinical Data on ART26.12 as Potential Non-Opioid Treatment for Osteoarthritis Pain at ICRS Symposium - Nasdaq

Jul 09, 2025

Jul 09, 2025

Breakthrough Pain Drug Matches Naproxen Efficacy Without Opioid Side Effects in Latest Trial - Stock Titan

Jul 09, 2025

Jul 09, 2025

Artelo Biosciences’ ART12.11 Shows Promising Antidepressant Effects in Preclinical Study - Insider Monkey

Jul 09, 2025